Express Scripts Holding (ESRX) Shares Sold by Calamos Advisors LLC
Calamos Advisors LLC trimmed its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 2.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 104,451 shares of the company’s stock after selling 2,215 shares during the period. Calamos Advisors LLC’s holdings in Express Scripts were worth $7,796,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC acquired a new stake in shares of Express Scripts during the 4th quarter worth $105,000. Aevitas Wealth Management Inc. acquired a new stake in Express Scripts in the 4th quarter valued at $128,000. Bank of Nova Scotia Trust Co. acquired a new stake in Express Scripts in the 3rd quarter valued at $120,000. Monroe Bank & Trust MI increased its holdings in Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new stake in Express Scripts in the 4th quarter valued at $183,000. Institutional investors and hedge funds own 86.45% of the company’s stock.
Express Scripts Holding (NASDAQ:ESRX) opened at $74.77 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The firm has a market cap of $41,800.00, a PE ratio of 9.66, a price-to-earnings-growth ratio of 0.88 and a beta of 0.94. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49.
Express Scripts declared that its Board of Directors has approved a stock repurchase program on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.
In other news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the transaction, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Glen D. Stettin sold 3,448 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 21,896 shares of company stock valued at $1,617,903. 0.68% of the stock is currently owned by corporate insiders.
Several brokerages recently issued reports on ESRX. Jefferies Group set a $91.00 price target on Express Scripts and gave the company a “buy” rating in a report on Wednesday. Zacks Investment Research downgraded Express Scripts from a “buy” rating to a “hold” rating in a report on Friday. Sanford C. Bernstein downgraded Express Scripts from a “market perform” rating to an “underperform” rating and increased their price target for the company from $55.80 to $77.50 in a report on Tuesday, January 30th. BidaskClub downgraded Express Scripts from a “strong-buy” rating to a “buy” rating in a report on Friday, February 2nd. Finally, Raymond James Financial reiterated a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Six research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $80.49.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.